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Abstract
Aims To determine the effects of high-intensity interval training (HIIT) following cardiac resynchronization therapy (CRT) 
implantation in patients with chronic heart failure (CHF), on noninvasive estimates of systolic ventricular function, exercise 
performance, severity of symptoms and quality of life.
Methods Cardiopulmonary exercise testing, resting transthoracic echocardiogram and health-related quality of life assess-
ment were obtained before and at 6 months after CRT implantation in 37 patients with moderate-to-severe CHF. Patients 
were randomized after CRT to either a 24-week HIIT group (90–95% peak heart rate, 2 days per week) or to a usual care 
group (CON). Mixed design 2 × 2 repeated measures ANOVA were used to test for differences within and in-between groups.
Results Improvements in health-related quality of life (HIIT = 98.54%, CON = 123.47%), NYHA class (HIIT = 43.44%, 
CON = 38.30%) HR recovery at minute 1 (HIIT = 32.32%, CON = 42.94%), pulse pressure at peak effort (HIIT = 14.06%, 
CON = 9.52%, LVEF (HIIT = 42.17%, CON = 51.10%) and LV Mass (HIIT = 13.26%, CON = 11.88%) were similar in 
both groups (p > 0.05). Significant increases in CPET duration in the HIIT group (25.94%), and increases in peak  VO2 
(HIIT = 8.64%, CON = 4.85%) and percent-predicted  VO2 (HIIT = 10.57%, CON = 4.26%) in both groups, were observed 
in the intention-to-treat analysis.
Conclusion Six months of HIIT in patients in CRT did not further improved indices of functional capacity and health-related 
quality of life, and LV structure and function, compared to CRT alone. However, HIIT led to further improvements in exercise 
performance. It remains unclear whether HIIT benefits patients in CRT to a similar degree as more conventional forms of 
exercise training previously shown to maximize benefits in CRT.
Clinical trial registration http://www.clini caltr ials.gov. Unique identifier: NCT02413151.
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HIIT  High-intensity interval training
HR  Heart rate
HR recovery 1 min  Heart rate recovery at 1 min after 
CPET
HR recovery 3 min  Heart rate recovery at 3 min after 
CPET
LV  Left ventricular
LVEF  Left ventricular ejection fraction
LV mass  Left ventricular mass
LV EDV  Left ventricular end-diastolic volume
LV ESV  Left ventricular end-systolic volume
NYHA  New York Heart Association Func-
tional Scale
Peak PP  Pulse pressure at peak effort during 
cardiopulmonary exercise testing
Peak RPP  Rate pressure product at peak effort 
during cardiopulmonary exercise 
testing
Peak HR  Heart rate at peak effort during car-
diopulmonary exercise testing
Peak  VO2  Oxygen consumption at peak effort 
during cardiopulmonary exercise 
testing
RER  Respiratory exchange ratio
Introduction
Cardiac resynchronization therapy (CRT) is recommended 
to reduce mortality and morbidity in patients with chronic 
heart failure (CHF) classified as New York Heart Associa-
tion (NYHA) functional class III–IV. These patients are 
symptomatic despite optimal medical therapy with a reduced 
left ventricular (LV) ejection fraction (LVEF) and prolonged 
QRS. CRT has been shown to improve prognosis (Cleland 
et al. 2005) leading to reverse ventricular remodeling with a 
reduction in LV size, improvement in the LVEF and reduc-
tions in systolic LV volume (Santos et al. 2015; Brignole 
et al. 2013). However, 20–30% of patients show no or only 
minor clinical or echocardiographic improvements (Abra-
ham et al. 2002). It is well accepted that exercise training is 
beneficial for patients with CHF producing improvements in 
peak oxygen consumption  (VO2), hemodynamics and health-
related quality of life (Keteyian et al. 2010; Ellingsen et al. 
2017). The Heart Failure: A Controlled Trial Investigating 
Outcomes of Exercise Training (HF-ACTION) trial has 
recently shown such improvements extend to patients with 
CHF classified as NYHA III–IV with and without pacing 
devices (Zeitler et al. 2015). Patients suitable for CRT are of 
a comparable functional status to those in the HF-ACTION 
trial, but the combination of exercise training and CRT has 
not been well-investigated. All four studies specifically 
designed to evaluate the effect of exercise training following 
CRT concluded that exercise training maximizes benefits 
in peak  VO2 (Patwala et al. 2009; Belardinelli et al. 2006; 
Conraads et al. 2007; Smolis-Bąk et al. 2015). However, the 
effect on NYHA classification, LV volumes and LVEF is 
not clear as abnormalities in LV systolic function were not 
associated with exercise capacity in patients referred to an 
exercise echocardiogram (Grewal et al. 2009). Furthermore, 
these studies initiated the exercise program 3 months after 
CRT, used short-term exercise training (2–4 months), and 
did not always describe the exercise load used in sufficient 
detail (Patwala et al. 2009; Belardinelli et al. 2006; Con-
raads et al. 2007; Smolis-Bąk et al. 2015). Exercise intensity 
is also an important factor for cardiovascular function and 
prognosis in patients with CHF and reduced LVEF (Ham-
brecht et al. 2000). Compared with traditional moderate-
intensity continuous training, emerging evidence indicates 
that HIIT provides equivalent if not indeed superior meta-
bolic, cardiac, and systemic vascular adaptations, thereby 
supporting more time-, retention- and physiological-efficient 
approaches to optimize metabolic and cardiovascular health 
(Guiraud et al. 2012; Wisloff et al. 2007; Wisløff et al. 2009; 
Weston et al. 2014). However, these health benefits have 
not yet been examined in patients in CRT. This knowledge 
would inform exercise prescription guidelines and allow 
exploration of alternative approaches to assess the health 
benefits that exercise provides for patients in CRT.
Therefore, we conducted a randomized controlled trial 
(RCT) in patients with CHF to determine the effects of a 
6-month HIIT program initiated soon after CRT implanta-
tion (2–4 weeks) on selected noninvasive estimates of sys-
tolic function, exercise performance, severity of symptoms 
and health-related quality of life.
Methods
Study population and randomization procedure
This study is a randomized, single-center control trial 
conducted from 2012 to 2015. One-hundred twenty-one 
patients, from Hospital Santa Marta, with CHF and referred 
for CRT were eligible for the study (Fig. 1). Patients were 
randomized and stratified (by gender, age and etiology) fol-
lowing CRT. The randomization code was developed with 
a computer random-number generator to select random 
permuted blocks. Fifty-eight patients were not randomized 
either because they declined to participate in the study or 
as a result of clinical changes during the CRT implantation. 
The remaining 63 patients with moderate-to-severe CHF 
(NYHA class II–IV who were under optimal medical ther-
apy with QRS > 120 ms) were randomized to HIIT (HIIT, 
n = 34) or to the usual care group (CON, n = 29). One patient 
from the HIIT group died during the study and 20 patients 
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successfully completed the exercise protocol with attendance 
above 80% during the 48 sessions including all evaluation 
visits. Three of the 29 control patients died during the study 
and 9 did not complete assessments (Supplement 1). There-
fore, 37 patients (HIIT, n = 20; CON, n = 17) completed the 
study. Exclusion criteria were: geographical distance from 
the hospital center (> 20 km), incapacitating orthopedic, 
neurologic, or other limitations that limiting exercise, declin-
ing to participate in the study, inability to sign the informed 
consent, previous treatment with an intravenous inotropic 
agent within the 30 days prior to implantation, or unsta-
ble angina pectoris. Optimal medical therapy for CHF was 
considered to include a diuretic, an angiotensin-converting 
enzyme inhibitor or an angiotensin receptor blocker and a 
beta-blocker, as recommended (Ponikowski et al. 2016).
All patients underwent cardiopulmonary exercise test-
ing, a resting transthoracic echocardiogram and health-
related quality of life assessment. All measurements 
were performed before CRT implantation and repeated 
6 months after implantation. The CON group was given 
no specific advice on exercise training and underwent 
no supervised training. No change in cardiac medication 
occurred as part of the study protocol. The study was per-
formed according to the Helsinki declaration, approved 
by the hospital medical ethics research committee and 
registered in Clinicaltrials.gov (NCT02413151). Written 
informed consent was obtained from all patients.
Fig. 1  Flow diagram of the study
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Cardiopulmonary exercise testing
A symptom-limited incremental cardiopulmonary exercise 
testing (CPET) was performed on a treadmill (Bruce pro-
tocol) with breath-by-breath gas exchange measurements 
(Innocor®, Innovision, Cardiosolutions) and online real-
time calculation of  VO2,  CO2peak production and respiratory 
exchange ratio (RER). Subjects were tested 2 h post-prandial 
and under the regular medication. A 12-lead electrocardio-
gram was recorded continuously, and blood pressure was 
measured by auscultation using an aneroid sphygmomanom-
eter (at rest, at the end of each stage and every min after peak 
effort). The pulse pressure (PP) and the rate pressure product 
(RPP) at rest and at peak effort were calculated. Subjects 
were encouraged to exercise until exhaustion, as defined 
by the inability to keep up with the treadmill speed, by leg 
fatigue or dyspnea, and RER values > 1.1, unless clinical 
criteria for earlier test termination were observed. Peak  VO2 
was considered the highest attained  VO2 during the final 
30 s of exercise (10 s average). Percent-predicted peak  VO2 
was calculated according to normative values proposed by 
Wasserman et al. (2012) (1 of 6 equations according to sex 
and bodyweight). Peak  O2 pulse was calculated as the ratio 
of peak  VO2 to peak heart rate, and the myocardial workload 
at peak effort was calculated as the rate pressure product.
Echocardiography parameters
Echocardiography was performed according to the guide-
lines of the American and European guidelines for echo-
cardiographic examination (Evangelista et al. 2008; Lang 
et al. 2015). Resting M-mode echocardiographic measure-
ments of LV end-diastolic and end-systolic diameter were 
performed from the parasternal long axis. LVEF and vol-
umes (LVESV and LVEDV) were quantified according to 
the modified Simpson’s rule (Schiller et al. 1989). Septal 
and posterior wall thickness were assessed by using linear 
measurements in parasternal long-axis view images at the 
level of LV minor axis, as previously suggested (Lang et al. 
2015). LV mass was calculated using the Devereux formula 
(Devereux et al. 1986).
Health‑related quality of life
Health-related quality of life was assessed using a validated 
Portuguese version of the HeartQoL, a 14-item self-adminis-
tered questionnaire enabling respondents to recall how much 
their heart problem bothered them during the past 4 weeks, 
which has been validated in patients with CHF (Oldridge 
et al. 2014). The HeartQoL is scored on a four-point Likert 
scale (0–3) with higher scores representing better health-
related quality of life. A global, physical and emotional 
HeartQoL score can be calculated (Oldridge et al. 2014).
Exercise training
The exercise sessions were supervised, hospital-based, elec-
trocardiogram monitored and implemented twice a week, 
each for 60 min, on non-consecutive days for 6 months (48 
sessions). During the first month, each interval training and 
active pause was increased by 30 s on a weekly basis, until 
accomplishing the 4 min work with 3 min of active rest. Every 
session included a 10-min warm up and a 5- to 7-min cool-
down. Starting from the second month, the HIIT consisted of 
4 interval training periods (high intensity: 90–95% of maximal 
heart rate if below the device threshold) with 3 lower-intensity 
active periods (moderate intensity: 60–70% of maximal heart 
rate if below the device threshold) between interval train-
ing periods (Wisloff et al. 2007). This HIIT regime had its 
effects compared and quantified against moderate-intensity 
continuous training in improving peak  VO2 in patients with 
lifestyle-induced chronic diseases (Weston et al. 2014). The 
results revealed this HIIT regime induced greater reductions in 
blood pressure, improved blood glucose control, and increased 
aerobic capacity to a greater extent than did exercise conducted 
according to traditional guidelines. Furthermore, no increase 
in adverse events was reported with HIIT.
Statistical analysis
Variables were examined for normality, skewness, and kurto-
sis by performing the Shapiro–Wilk test of normality, visual 
inspection of normal quantile and histogram plots, and kurto-
sis and skewness summary statistics. Variables with a skewed 
distribution were log transformed for parametric statistical 
analyses.
Differences between groups at baseline and post-interven-
tion, changes over time within each group and any interaction 
effect were assessed by mixed designed two-way repeated 
measures analysis of variance (ANOVA). Proportions were 
compared using Chi squared test.
Since this study was designed as an efficacy study, we 
focused initially on a per-protocol analyses, which included 
the patients in CRT that successfully completed the exercise 
protocol with attendance rates superior to 80%. Next, we per-
formed an intention-to-treat analysis using all participants that 
were randomized.
Statistical significance level was set at p < 0.05 for all tests. 
The statistical analyses were computed and analyzed using the 
SPSS Statistics 24.0 (SPSS Inc., Chicago, IL, USA).
Results
Baseline characteristics of the 37 patients in CRT who met 
the per-protocol criteria are displayed in Table 1. Health-
related quality of life, functional class, exercise 
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performance and echocardiographic parameters are sum-
marized in Table 2 for patients in CRT who met the per-
protocol criteria, and in Supplement 2 for all patients in CRT 
as randomized.
Functional capacity and health‑related quality 
of life
No significant differences were found between the HIIT and 
CON groups in functional capacity scale or health-related 
quality of life at baseline.
Health-related quality of life increased (HIIT = 98.5%, 
CON = 123.5%; p < 0.001; η2 = 0.535) and NYHA score 
decreased similarly in both groups (HIIT = 43.4%, 
CON = 38.3%; p < 0.001; η2 = 0.623; Table 2). The rate of 
clinical responders (sustained improvement LVEF ≥ 15%) 
in the HIIT group was 83.9% and in the CON group was 
73.9% (p = 0.371).
Similar results were observed in the intention-to-treat 
analysis (Supplement 3).
Exercise performance
No significant differences were found between the HIIT 
and CON groups in any exercise performance parameter at 
baseline.
Table 1  Characteristics of the participants previous to CRT implanta-
tion, presented by randomization groups performed a posteriori
Values are expressed as mean ± SEM
HIIT High-intensity interval training, CRT cardiac resynchronization 
therapy, CON control
Unit HIIT CON
Subjects (n) 20 17
Age (years) 68 ± 2 67 ± 2
Males (%) 76.5 75.0
Etiology (%)
 Ischaemic 41.9 35.7




 ACE inhibitors 92.6 88.2
 Diuretics 96.3 88.2
Sinus rhythm (%) 55.9 42.9
QRS width (ms) 150±4 144±9
Body mass index (kg/m2) 26.3±1.0 28.7±1.2
Heart rate (bpm) 80.95±3.44 78±4
Systolic blood pressure (mmHg) 114±4 121±4
Diastolic blood pressure (mmHg) 63±2 66±3
Table 2  Quality of life, functional class, exercise performance and 
echocardiographic parameters in HIIT and control CRT patients who 
met the per-protocol criteria
HIIT CON Pinteraction effect
Quality of life (unitless)
 Baseline 1.0 ± 0.1 0.8 ± 0.2 0.879
 Post-intervention 1.9 ± 0.1* 1.8 ± 0.2*
NYHA (unitless)
Baseline 2.7 ± 0.6 2.8 ± 0.4 0.668
Post-intervention 1.5 ± 0.7* 1.7 ± 0.6*
Peak  VO2 (mL.kg−1.min−1)
Baseline 14.0 ± 1.4 17.4 ± 1.7 0.5
Post-intervention 15.7 ± 1.0 18.0 ± 1.3
Predicted peak  VO2 (%)
Baseline 54.6 ± 4.1 68.0 ± 5.3 0.685
Post-intervention 61.7 ± 3.8 72.5 ± 4.9
CPET duration (s)
Baseline 372 ± 56 478 ± 75 0.099
Post-intervention 548 ± 50* 503 ± 66*
RER (unitless)
Baseline 0.99 ± 0.03 0.99 ± 0.04 0.581
Post-intervention 1.02 ± 0.02 0.98 ± 0.03
Peak PP (mmHg)
Baseline 71 ± 4 75 ± 5 0.674
Post-intervention 81 ± 4* 82 ± 5*
Peak RPP 
(mmHg*bpm*10−3)
Baseline 17.0 ± 1.0 19.5 ± 1.2 0.701
Post-intervention 17.0 ± 1.1 18.9 ± 1.3
Peak  O2 pulse (mL.beat−1)
Baseline 8.4 ± 0.9 10.7 ± 1.1 0.869
Post-intervention 9.7 ± 0.9 11.8 ± 1.1
Peak HR (bpm)
Baseline 122 ± 5 130 ± 6 0.790
Post-intervention 120 ± 4 126 ± 5
HR recovery 1′ (bpm)
Baseline 15 ± 2 15 ± 3 0.732
Post-intervention 19 ± 3* 21 ± 3*
HR recovery 3 min (bpm)
Baseline 35 ± 4 37 ± 5 0.754
Post-intervention 37 ± 4 41 ± 5
LVEF (%)
Baseline 27.0 ± 1.4 25.5 ± 1.6 0.590
Post-intervention 38.3 ± 2.0* 38.6 ± 2.3*
LV mass (g)
Baseline 309 ± 25 360 ± 31 0.947
Post-intervention 268 ± 23* 318 ± 28*
LVEDV (mL)
Baseline 197 ± 18 239 ± 20 0.472
Post-intervention 199 ± 20 229 ± 22
LVESV (mL)
Baseline 140 ± 18 178 ± 17 0.143
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CPET duration increased in both groups (HIIT = 47.4%, 
CON = 5.1%; p = 0.008; η2 = 0.205; Fig. 2; Table 2). This 
improvement was neither coincident with an increase in 
peak  VO2 (p = 0.134; η2 = 0.073) nor percent-predicted peak 
 VO2 (p = 0.07; η2 = 0.109). However, in the intention-to-treat 
analysis we observed an interaction effect suggesting that 
CPET duration increased only in the HIIT group (25.9%; 
p = 0.013; η2 = 0.108; Supplement 2), and an increase in peak 
 VO2 (HIIT = 8.6%, CON = 4.9%; p = 0.047; η2 = 0.068) and 
percent-predicted peak  VO2 (HIIT = 10.6%, CON = 4.3%; 
p = 0.05; η2 = 0.081) in both groups.
Changes in CPET duration were associated with changes 
in peak  VO2 (HIIT r = 0.595, p = 0.006; CON r = 0.727, 
p = 0.007) and percent-predicted peak  VO2 (HIIT r = 0.582, 
p = 0.007; CON r = 0.681, p = 0.015) in both analyses 
(Supplement 3). HR recovery at minute 1 increased in 
both groups (HIIT = 32.3%, CON = 42.9%; p = 0.026; 
η2 = 0.165; Table 2) but not at minute 3 following CPET 
(p = 0.47; η2 = 0.018).  O2 pulse did not change in either 
group (p = 0.087; η2 = 0.095).
Pulse pressure at peak effort increased similarly in both 
groups (HIIT = 14.1%, CON = 9.5%; p = 0.01; η2 = 0.176). 
The wider pulse pressure at peak effort in the HIIT group 
did not influence the myocardial workload at peak effort 
(Table 2). Similar results were observed in the intention-to-
treat analysis (Supplement 3).
Echocardiographic parameters
No significant differences were found between HIIT and 
CON groups in any echocardiographic parameter at baseline.
Increases in LVEF (HIIT = 42.2%; CON = 51.10%; 
p < 0.001; η2 = 0.552) and decreases in LV mass 
(HIIT = 13.26%, CON = 11.9%; p = 0.005; η2 = 0.240) were 
observed in both groups (Fig. 3; Table 2). Neither changes 
in LVEF nor LV mass were significantly associated with 
changes in exercise performance. LV volumes did not 
change significantly with time, and these results were simi-
lar when values were adjusted for body surface area (data 
not shown). However, LVESV decreased in both groups in 
the intention-to-treat analysis (HIIT = 5.1%, CON = 13.0%; 
p = 0.021; η2 = 0.093; Supplement 2).
Discussion
The major findings of this study were that 6 months of HIIT 
in combination with CRT did not further improve indices of 
functional capacity and health-related quality of life, and LV 
structure and function, compared to CRT alone. However, 
Table 2  (continued)
HIIT CON Pinteraction effect
Post-intervention 140 ± 20 149 ± 19
Values are expressed as mean ± SEM. *Significant time effects 
(p < 0.05)
HIIT, high-intensity interval training; CRT, cardiac resynchroniza-
tion therapy; CON, control; P change score, significance of differ-
ences between change scores (HIIT vs CON); NYHA, New York 
Heart Association Functional Class; Peak PP, pulse pressure at peak 
effort during cardiopulmonary exercise testing; Peak RPP, rate pres-
sure product at peak effort during cardiopulmonary exercise testing; 
Peak HR, heart rate at peak effort during cardiopulmonary exercise 
testing; Peak VO2, oxygen consumption at peak effort during car-
diopulmonary exercise testing;  %-predicted  VO2, calculated accord-
ing to normative values proposed by Wasserman et al. (2012); CPET 
duration, cardiopulmonary exercise testing duration; RER, respiratory 
exchange ratio; HR recovery 1 min, heart rate recovery at 1 min after 
CPET; HR recovery 3 min, Heart rate recovery at 3 min after CPET; 
LVEF, left
Fig. 2  Percentage changes on selected exercise performance param-
eters derived from the mixed designed two-way repeated measures 
ANOVA are presented for group with the per-protocol analysis and 
the intention-to-treat analysis. The graphs display absolute percent-
ages (positive signs only); *Significant time effect (p < 0.05). HIIT 
High-intensity interval training, CON control, CPET duration car-
diopulmonary exercise testing duration. %-predicted VO2 calculated 
according to normative values proposed by Wasserman et al. (2012), 
Peak VO2 peak oxygen consumption during CPET
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HIIT led to further improvements in exercise performance 
compared to CRT alone.
Health‑related quality of life and functional 
capacity
The changes in health-related quality of life and NYHA 
class were similar between the two groups suggesting no 
additional benefits of HIIT following CRT. Thus, the effect 
of CRT itself was equally benefic without adding exercise 
training, even in changes in exercise tolerance and LVEF 
(Smolis-Bąk et al. 2015). However, previous literature shows 
that the improvements achieved may be maintained longer 
if patients continue exercising (Hussein and Thomas 2008).
Exercise capacity is usually improved following CRT 
(Auricchio et al. 2002) and a small number of studies have 
shown that exercise training following CRT produces further 
improvements (Patwala et al. 2009; Belardinelli et al. 2006; 
Smolis-Bąk et al. 2015; Conraads et al. 2007). Follow-
ing 3–4 months of structured exercise training in patients 
in CRT, peak  VO2 values, exercise duration and maximal 
workload achieved have been shown to increase (Patwala 
et  al. 2009; Belardinelli et  al. 2006; Smolis-Bąk et  al. 
2015; Conraads et al. 2007). In general, improvements of 
18–25% in peak  VO2 and 18–34% in CPET duration have 
been reported with exercise in CHF patients (Downing and 
Balady 2011). In the present study, CPET duration increased 
up to 47.4% in HIIT in the per-protocol analysis, but the 
interaction effects were only significant in the intention-to-
treat analysis with increments of 25.9% in the HIIT group 
(p = 0.013; η2 = 0.108). It is possible that adding HIIT to 
CRT improves walking performance and efficiency factors, 
contributing to positive effects on the economy of motion 
(Beneke and Meyer 1997) with expectable benefits in the 
performance of daily activities.
Another finding was the increase in peak pulse pres-
sure observed in both groups. The rise in pressure from its 
diastolic to systolic value is determined by compliance of 
the aorta as well as ventricular stroke volume. Thus, we 
may theoretically assume an improvement in any of these 
throughout the study. Importantly, this occurred without sig-
nificant changes in pulse pressure or LV volumes at rest, and 
without affecting myocardial oxygen uptake requirements.
Echocardiographic parameters
CRT reduces LV volumes, increases LV function (St John 
Sutton et al. 2003) and is strongly correlated with subse-
quent favorable clinical and arrhythmia outcomes (Kutyifa 
et al. 2013; Goldenberg et al. 2011). CRT is also associated 
with significant decreases in LV mass, septal and posterior 
wall thickness in mild and advanced CHF (St John Sutton 
et al. 2003; Kutyifa et al. 2013), indicative of LV structural 
reverse remodeling. Studies testing exercise as an adjuvant 
therapeutic to CRT also showed a decrease in LV volumes 
(Conraads et al. 2007; Smolis-Bąk et al. 2015; Belardinelli 
et al. 2006). However, this is not a universal finding and 
the percent changes in volumetric reverse remodeling are 
equivocal following CRT (St John Sutton et al. 2009; Pat-
wala et al. 2009). Our analysis showed that no added benefits 
occurred in myocardial structure when HIIT was combined 
with CRT. Although this study was not designed to observe 
correlations between changes in LV volumes and LV mass, 
structural reverse remodeling following CRT has long been 
described as a late sequel of volumetric reverse remodeling 
(Zhang et al. 2006). However, that may not be the case in the 
present study. In the belief that changes in the structure and 
volume of the myocardium are parts of the same process, we 
can only infer that LV structural reverse remodeling in these 
patients was due to changes in interventricular septal and/or 
Fig. 3  Percentage changes on selected echocardiographic param-
eters derived from the mixed designed two-way repeated measures 
ANOVA are presented for group with the per-protocol analysis and 
the intention-to-treat analysis. The graphs display absolute percent-
ages (positive signs only); *Significant time effect (p < 0.05). HIIT 
High-intensity interval training, CON control, LVEF left ventricular 
ejection fraction, LV mass left ventricular mass, LVESV left ventricu-
lar end-systolic volume
1764 European Journal of Applied Physiology (2019) 119:1757–1767
1 3
posterior wall thickness at end-diastole, reflecting a lower 
regional wall stress (Mannaerts 2006), and that LV volu-
metric and structural changes may not always coincide. The 
interaction of these variables is difficult to ascertain, espe-
cially when comparison studies have different time frames. 
Still, it is compatible with observations that benefits of CRT 
take time to materialize (Yu et al. 2002).
Exercise training
Most exercise training studies in patients with CHF 
employ moderate-to high-intensity exercise (70–80% peak 
HR) (Downing and Balady 2011). We recognize that this 
exercise training program was more intense and longer 
than the usual cardiac rehabilitation offered to patients 
after myocardial infarction or coronary revascularization, 
and also when compared to more unconventional trials 
even in CRT. It is only during the last decade that HIIT 
has emerged, but it appears to be more advantageous in 
improving peak  VO2 and ventricular remodeling parame-
ters in patients with CHF (Guiraud et al. 2012). However, 
we and others showed that this is not a universal finding 
(Dimopoulos et al. 2006; Roditis et al. 2007; Iellamo et al. 
2013; Ellingsen et al. 2017). There are no data yet regard-
ing the adherence to HIIT in patients with CHF but, in 
coronary artery patients, the long-term adherence to HIIT 
has been shown to be superior- to moderate-intensity 
continuous exercise (Meyer et al. 2013), and to be per-
ceived as a more enjoyable training modality in healthy 
adults (Bartlett et al. 2011). In our study, some patients 
felt that the 6-month HIIT protocol with active recovery 
was difficult to tolerate. HIIT prescription of 90–95% of 
maximal heart rate may be too high for some patients. 
As this appears to be associated with a reduced ability to 
complete exercise sessions due to fatigue and exhaustion, 
continuous aerobic training with the gradual inclusion 
of short-interval HIIT sessions using passive recovery 
may be more suitable for less fit or higher-risk patients 
with cardiac disease (Gayda et al. 2016). We and others 
(Ellingsen et al. 2017) suggest that exercise intensities 
should be regularly adapted to improvements in exercise 
capacity as well as worsening of symptoms or changes of 
medication. Repeated assessment of maximal heart rate 
and more emphasis on adjusting workload according to 
perceived level of effort might also be helpful. Therefore, 
a single exercise protocol is probably not suitable to all 
patients and should be individualized. Still, in patients 
with cardiac disease, who often report a lack of time as a 
reason for not exercising, HIIT may be considered a time-
efficient substitute or alternative (or both) to traditional 
continuous aerobic training (Gayda et al. 2016).
Limitations
We did not mean to test the optimal timing to start exercise 
after CRT, or to compare intensities of exercise training. 
Therefore, this study should be carefully interpreted con-
sidering these and the following limitations. The per-pro-
tocol analysis tended to show superior benefits in the HIIT 
group, but these were only supported by significant interac-
tion effects in the intention-to-treat analysis. This probably 
reflects the relatively small number of patients in each group 
and the wide standard deviations. Still, the intention-to-treat 
analysis provides an unbiased estimate of the efficacy of 
HIIT in patients in CRT.
The use of target HR zones is often not reliable in CHF 
due to frequent chronotropic incompetence, high prevalence 
of chronic atrial fibrillation, and constant occurrence of HR 
drift during exercise. As a result, exercise workloads cor-
responding to an individualized percentage of peak  VO2 
should be employed to prescribe HIIT intensity.
Additionally, cardiac function was assessed only at rest, 
just before CPET, and we did not evaluate cardiac func-
tion during exercise. This could have been interesting as the 
predictive ability of selected parameters may change during 
stress echocardiography.
Dropout was nearly 41% with HITT, slightly lower than 
results recorded in most European countries where the pro-
portion of patients participating in post-hospital rehabilita-
tion was below 50% (Bjarnason-Wehrens et al. 2010). How-
ever, this may still have biased the results.
Future directions
It remains unclear whether HIIT benefits patients in CRT 
to a similar degree as more conventional forms of exercise 
training previously shown to maximize benefits in CRT (Pat-
wala et al. 2009). HIIT in patients in CRT should be assessed 
in combination with other training regimes (inspiratory 
muscle training, resistance training), in different exercise 
allocations (hospital-based and telemonitoring guided home-
based training) and different times from device implantation. 
It should also be examined with respect to intensity, duration 
of intervals and progression model.
Conclusions and future directions
Six months of HIIT in patients in CRT produced improve-
ments in indices of functional capacity and health-related 
quality of life, exercise performance, and LV structure and 
function. However, HIIT only led to further improvements 
in exercise performance.
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